Abstracts deadline Friday 24 April 2026! Submit now

d
h
m
s

Abstracts deadline EXTENDED Friday 22 May 2026! Submit now

d
h
m
s
Days
Hrs
Mins

Dr Alhanouf Alsaleem

Dr.Alhanouf Alsaleem received her medical degree from the King Saud University in Riyadh, Saudi Arabia.She completed her pediatric residency training at King Faisal Specialist Hospital and Research Centre (KFSHRC). She subsequently pursued fellowship training in pediatric rheumatology at The Hospital for Sick Children (Toronto, CA). Following her fellowship, Dr. Alhanouf completed advanced subspecialty training as a post doc research fellow at the Translational Autoinflammatory Diseases Section at the National Institutes of Health (Bethesda, USA) and she continued her research work as a guest researcher at the NIH.
Currently, Dr. Alhanouf serves as the Program Director of the Pediatric Rheumatology Fellowship Training Program at KFSHRC.
Alongside her senior colleague, Dr. Suleiman Al-Maayouf, they co-founded the Autoinflammatory Disease Specialized Clinic at KFSHRC to advance patient care, translational research, and clinical research for patients with rare autoinflammatory and immune dysregulation conditions.
Dr. Alhanoufs research focuses on the development of international registries for systemic autoinflammatory diseases and immune dysregulation disorders across the Asia-Pacific and MENA regions. Her research work particularly centered on the evolving landscape of autoinflammatory diseases, with a special emphasis on genetic discoveries, translational and clinical research.

Dr.Alhanouf Alsaleem received her medical degree from the King Saud University in Riyadh, Saudi Arabia.She completed her pediatric residency training at King Faisal Specialist Hospital and Research Centre (KFSHRC). She subsequently pursued fellowship training in pediatric rheumatology at The Hospital for Sick Children (Toronto, CA). Following her fellowship, Dr. Alhanouf completed advanced subspecialty training as a post doc research fellow at the Translational Autoinflammatory Diseases Section at the National Institutes of Health (Bethesda, USA) and she continued her research work as a guest researcher at the NIH. Currently, Dr. Alhanouf serves as the Program Director of the Pediatric Rheumatology Fellowship Training Program at KFSHRC. Alongside her senior colleague, Dr. Suleiman Al-Maayouf, they co-founded the Autoinflammatory Disease Specialized Clinic at KFSHRC to advance patient care, translational research, and clinical research for patients with rare autoinflammatory and immune dysregulation conditions. Dr. Alhanoufs research focuses on the development of international registries for systemic autoinflammatory diseases and immune dysregulation disorders across the Asia-Pacific and MENA regions. Her research work particularly centered on the evolving landscape of autoinflammatory diseases, with a special emphasis on genetic discoveries, translational and clinical research.

Sessions

Presentations

Share

Key dates

Registrations
Abstracts

More speakers

Prof Gulen Hatemi
Istanbul University - Cerrahpasa. Turkiye
Prof Susanna Proudman
Royal Adelaide Hospital, Australia
A/Prof Paulo Lorenzo
President, APLAR. Philippines
Prof Tsutomu Takeuchi (竹内勤)
Saitama Medical University, Keio University, East Asia
Prof. Xenofon Baraliakos
Rheumazentrum Ruhrgebiet, Europe
Prof Soumya Raychaudhuri
Harvard Medical School, Brigham and Women's Hospital, United States
Days
Hours
Minutes
Seconds
Until 11:59PM AEST Tuesday 23 June, 2026

The countdown is on

Have you registered yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.

Days
Hours
Minutes
Seconds
Until 11:59PM AEST Friday 24 April, 2026

The countdown is on

Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.